BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Münz C. Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice. Vaccines (Basel) 2019;7:E217. [PMID: 31861045 DOI: 10.3390/vaccines7040217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Granato M. Nanotechnology Frontiers in γ-Herpesviruses Treatments. Int J Mol Sci 2021;22:11407. [PMID: 34768838 DOI: 10.3390/ijms222111407] [Reference Citation Analysis]
2 Chen H, Zhong L, Zhang W, Zhang S, Hong J, Zhou X, Zhang X, Feng Q, Chen Y, Zeng YX, Xu M, Krummenacher C, Zhang X. Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses. Viruses 2021;13:2184. [PMID: 34834989 DOI: 10.3390/v13112184] [Reference Citation Analysis]
3 Xu-Monette ZY, Young KH. Therapeutic vaccines for aggressive B-cell lymphoma. Leuk Lymphoma 2020;61:3038-51. [PMID: 32840404 DOI: 10.1080/10428194.2020.1805113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]